Indications & Dose:
Severe acute asthma in patients not previously treated with theophylline
Child: 5 mg/kg (max. per dose 500 mg), to be followed by intravenous infusion
Adult: 250–500 mg (max. per dose 5 mg/kg), to be followed by intravenous infusion
Severe acute asthma
Child 1 month–11 years: 1 mg/kg/hour, adjusted according to plasma-theophylline concentration
Child 12–17 years: 500–700 micrograms/kg/hour, adjusted according to plasma-theophylline concentration
Adult: 500–700 micrograms/kg/hour, adjusted according to plasma-theophylline concentration
Elderly: 300 micrograms/kg/hour, adjusted according to plasma-theophylline concentration
Severe acute exacerbation of chronic obstructive pulmonary disease in patients not previously treated with theophylline
Adult: 250–500 mg (max. per dose 5 mg/kg), to be followed by intravenous infusion
Severe acute exacerbation of chronic obstructive pulmonary disease
Adult: 500–700 micrograms/kg/hour, adjusted according to plasma-theophylline concentration
Elderly: 300 micrograms/kg/hour, adjusted according to plasma-theophylline concentration
Chronic asthma
Child (body-weight 40 kg and above): Initially 225 mg twice daily for 1 week, then increased if necessary to 450 mg twice daily, adjusted according to plasmatheophylline concentration
Reversible airway obstruction
Adult (body-weight 40 kg and above): Initially 225 mg twice daily for 1 week, then increased if necessary to 450 mg twice daily, adjusted according to plasmatheophylline concentration
Contraindications:
Side Effects:
Cautions:
Precautions:
Elderly, CHF, corpulmonale, hepatic disease, preexisting dysrhythmias, hypertension, infants <1 yr, hypoxemia, sustained high fever, history of peptic ulcer, alcoholism
PREGNANCY AND LACTATION: Pharmacokinetics of theophylline may be altered during pregnancy, monitor serum concentrations carefully; excreted into breast milk; may cause irritability in the nursing infant, otherwise compatible with breast feeding
Interaction:
Drugs
Adenosine: Decreased hemodynamic effects of adenosine
Alluprinol, Amiodarone, Cimetidine, Ciproflaxacin, Disul firam, Erythromycin, Interferon alfa, Isoniazid, Metamizole,
Metoprolol, Narfloxacin, Pefloxacin, Pentoxifylline, Prapafenane, Prapylthiouraeil,
Radioactive iodine, Tacrine, Thiabendazale,
Ticlopidine, Verapamil: Increased theophylline concentrations
Aminoglutethamide, Barbiturates, Carbamazepine,
Maricizine, Phenytoin, Rifampin, Ritanavir; Thyroid hormone: Reduced theophylline concentrations; decreased serum phenytoin levels
Beta-blackers: Reduced bronchodilating response to theophylline Enoxacin; Fluvoxamine, Mexiletine, Propranolal,
Troleandomycin: Markedly increased theophylline concentrations
Imipenem: Some patients on theophylline have developed seizures following addition of imipenem
Lithium: Reduced lithium concentrations
Smoking: Increased aminophylline dosing requirements
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
CNS: Anxiety, dizziness, headache, insomnia, lightheadedness, muscle twitching, reflex hyperexcitability, restlessness, seizures
CV: Circulatory failure, flushing, hy potension, palpitations, sinus tachy cardia, ventricular dysrhythmias
GI: Anal irritation (suppositories), anorexia, bitter taste, black stools, diarrhea, dyspepsia, epigastric pain, esophageal reflux, hematemesis, nausea, vomiting
GU: Proteinuria, urinary frequency
METAB: Hyperglycemia, S1ADH
RESP: Tachypnea
SKIN: Urticaria, alopecia
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team